Related Experiment Videos
A biotin-protein bond with stability in plasma
Anna Bogusiewicz1, Nell I Mock, Donald M Mock
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Analytical Biochemistry
|January 15, 2005
Summary
Researchers developed a stable biotin label for proteins, crucial for pharmacokinetic studies in vulnerable populations. This new method ensures the biotin label remains attached in plasma, unlike current reagents.
Area of Science:
- Biochemistry
- Protein Chemistry
Background:
- A stable, nonradioactive label for peptide hormones is needed for pharmacokinetic studies in infants, children, and pregnant women.
- Biotin's high affinity for avidin makes it suitable for protein detection, but current biotinylation reagents yield labels unstable in plasma.
Purpose of the Study:
- To synthesize a stable biotin label for proteins.
- To assess the stability of this novel biotin-protein bond in plasma.
Main Methods:
- Immunoglobulin G (IgG) was used as a model protein and biotin was conjugated via a cysteine residue with a strategically positioned carboxylate group.
- Stability was evaluated by measuring biotin release in plasma and buffer controls using ultrafiltration and an avidin-binding assay.
Main Results:
- Less than 0.6% of bound biotin was released in plasma, comparable to buffer controls.
- This release rate was significantly lower than that observed with N-hydroxysuccinimide-LC-biotinylation.
Conclusions:
- The developed biotin-protein bond demonstrates high stability in plasma.
- This novel biotinylation method has the potential to improve various applications of avidin-biotin technology.